Forbes trashing a 5 dollar biotech? Really? | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  12111 of 12171  at  6/30/2020 11:43:16 AM  by

rwehapi


 In response to msg 12109 by  lysander_us
view thread

Re: Forbes trashing a 5 dollar biotech? Really?

 Looks like Forbes chose to plug in some numbers and spit out a report.  Nothing about pipeline which is the reason we are all here - I think.  
 
If 4430 is going to be of any help in offsetting medical resources taken up by seasonal flu, they should be ramping up production now - JS said the 3-6 month timeline for RNA treatment production like Remdesivir was about right  and they only had enough for 4430 trials in Brazil.
 
So far JS has been fairly accurate about the expected news flow dealing with pre-COVID pipeline including the surprise early auth for Orladeyo.  Still, it's difficult not to be excited about getting news for 4430 at some point over the summer.
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 159
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...